======= KIF18A ======= == Gene Information == * **Official Symbol**: KIF18A * **Official Name**: kinesin family member 18A * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=81930|81930]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8NI77|Q8NI77]] * **Interactions**: [[https://thebiogrid.org/search.php?search=KIF18A&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KIF18A|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611271|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Microtubule-depolymerizing kinesin which plays a role in chromosome congression by reducing the amplitude of preanaphase oscillations and slowing poleward movement during anaphase, thus suppressing chromosome movements. May stabilize the CENPE-BUB1B complex at the kinetochores during early mitosis and maintains CENPE levels at kinetochores during chromosome congression. {ECO:0000269|PubMed:17346968, ECO:0000269|PubMed:18267093, ECO:0000269|PubMed:18513970, ECO:0000269|PubMed:19625775}. |Kinesin| |tubulin-dependent ATPase activity| |mitotic spindle astral microtubule| |kinetochore microtubule| |seminiferous tubule development| |mitotic spindle midzone| |microtubule plus-end binding| |microtubule depolymerization| |ATP-dependent microtubule motor activity, plus-end-directed| |protein depolymerization| |cellular response to estradiol stimulus| |mitotic metaphase plate congression| |male meiotic nuclear division| |microtubule polymerization or depolymerization| |kinesin complex| |metaphase plate congression| |microtubule motor activity| |establishment of chromosome localization| |chromosome localization| |caveola| |retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum| |kinetochore| |ruffle| |antigen processing and presentation of exogenous peptide antigen via MHC class II| |antigen processing and presentation of peptide or polysaccharide antigen via MHC class II| |antigen processing and presentation of peptide antigen via MHC class II| |mitotic sister chromatid segregation| |male gonad development| |development of primary male sexual characteristics| |response to estradiol| |cellular protein complex disassembly| |sister chromatid segregation| |mitotic nuclear division| |meiotic nuclear division| |microtubule cytoskeleton| |male sex differentiation| |microtubule organizing center| |meiotic cell cycle process| |antigen processing and presentation of exogenous peptide antigen| |antigen processing and presentation of exogenous antigen| |regulation of microtubule cytoskeleton organization| |antigen processing and presentation of peptide antigen| |gonad development| |antigen processing and presentation| |development of primary sexual characteristics| |nuclear chromosome segregation| |regulation of microtubule-based process| |meiotic cell cycle| |ATPase activity| |microtubule binding| |protein-containing complex disassembly| |sex differentiation| |actin binding| |microtubule-based movement| |chromosome segregation| |nuclear division| |organelle fission| |microtubule| |cellular process involved in reproduction in multicellular organism| |establishment of organelle localization| |Golgi vesicle transport| |cellular component disassembly| |reproductive structure development| |reproductive system development| |supramolecular fiber organization| |microtubule cytoskeleton organization| |cellular response to lipid| |regulation of cytoskeleton organization| |cellular response to organic cyclic compound| |male gamete generation| |organelle localization| |mitotic cell cycle process| |cellular response to hormone stimulus| |developmental process involved in reproduction| |microtubule-based process| |mitotic cell cycle| |gamete generation| |multicellular organismal reproductive process| |sexual reproduction| |multicellular organism reproduction| |tube development| |response to lipid| |response to hormone| |response to organic cyclic compound| |multi-organism reproductive process| |cell cycle process| |cellular response to oxygen-containing compound| |chromosome organization| |cytoskeleton organization| |cellular response to endogenous stimulus| |regulation of organelle organization| |cell cycle| |reproductive process| |reproduction| |response to endogenous stimulus| |ATP binding| |protein transport| |peptide transport| |movement of cell or subcellular component| |response to oxygen-containing compound| |amide transport| |establishment of protein localization| |establishment of localization in cell| |nitrogen compound transport| |protein-containing complex subunit organization| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp125|GSK461364A 0.005μM R03 exp125]]|-5.81| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|-4.6| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|-4.36| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|-4.14| |[[:results:exp453|B02 10μM R08 exp453]]|-3.32| |[[:results:exp238|Parthenolide 2.5μM R05 exp238]]|-3.31| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-2.89| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|-2.73| |[[:results:exp485|GSK626616 14μM R08 exp485]]|-2.65| |[[:results:exp290|LLY-283 2.6μM R06 exp290]]|-2.6| |[[:results:exp210|LB-100 2μM R05 exp210]]|-2.52| |[[:results:exp449|Arsenic trioxide 60μM R08 exp449]]|-2.31| |[[:results:exp147|Resveratrol 16μM R03 exp147]]|-2.14| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|-2.13| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|-2.12| |[[:results:exp467|CAY10603 0.55μM R08 exp467]]|-2.11| |[[:results:exp146|Quinacrine 2.5μM R03 exp146]]|-2.11| |[[:results:exp107|UMK57 0.6μM R03 exp107]]|-2.1| |[[:results:exp128|GSK591 2.6μM R03 exp128]]|-2.07| |[[:results:exp264|Arsenate 40μM R06 exp264]]|-2.02| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|-1.96| |[[:results:exp59|UMK57 1μM R01 exp59]]|-1.95| |[[:results:exp277|Curcumin 6.5μM R06 exp277]]|-1.88| |[[:results:exp506|Momordin-Ic 10μM R08 exp506]]|1.84| ^Gene^Correlation^ |[[:human genes:s:ska1|SKA1]]|0.533| |[[:human genes:a:aspm|ASPM]]|0.42| |[[:human genes:a:actr1b|ACTR1B]]|0.416| |[[:human genes:r:rbbp4|RBBP4]]|0.416| |[[:human genes:g:gak|GAK]]|0.414| |[[:human genes:a:aar2|AAR2]]|0.413| |[[:human genes:a:actr1a|ACTR1A]]|0.408| |[[:human genes:k:kif15|KIF15]]|0.403| Global Fraction of Cell Lines Where Essential: 524/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|22/28| |blood|13/28| |bone|17/26| |breast|21/33| |central nervous system|45/56| |cervix|3/4| |colorectal|12/17| |esophagus|7/13| |fibroblast|1/1| |gastric|10/16| |kidney|18/21| |liver|17/20| |lung|49/75| |lymphocyte|14/16| |ovary|17/26| |pancreas|20/24| |peripheral nervous system|14/16| |plasma cell|6/15| |prostate|1/1| |skin|17/24| |soft tissue|7/9| |thyroid|1/2| |upper aerodigestive|20/22| |urinary tract|25/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2932 * **Expression level (log2 read counts)**: 5.36 {{:chemogenomics:nalm6 dist.png?nolink |}}